LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for MoonLake Immunotherapeutics (NASDAQ: MLTX) and Millions of Other Companies

Sign up for full access to MoonLake Immunotherapeutics (NASDAQ: MLTX) information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Loading spinner
Gathering insights about MoonLake Immunotherapeutics (NASDAQ: MLTX)…

Similar companies to MoonLake Immunotherapeutics (NASDAQ: MLTX)

✕

Access Insights for MoonLake Immunotherapeutics (NASDAQ: MLTX) and Millions of Other Companies

Sign up for full access to MoonLake Immunotherapeutics (NASDAQ: MLTX) information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

MoonLake Immunotherapeutics (NASDAQ: MLTX) Tech Stack

MoonLake Immunotherapeutics (NASDAQ: MLTX) uses 8 technology products and services including CookieYes, Font Awesome, PHP, and more. Explore MoonLake Immunotherapeutics (NASDAQ: MLTX)'s tech stack below.

  • CookieYes
    Cookie Compliance
  • Font Awesome
    Font Scripts
  • PHP
    Programming Languages
  • Akamai Web Application Protector
    Security
  • Microsoft Teams
    Team Collaboration
  • Google Universal Analytics
    Web Analytics
  • Zoom
    Web Conferencing
  • Twenty Twenty
    Web Platform Extensions

Media & News

MoonLake Immunotherapeutics (NASDAQ: MLTX)'s Email Address Formats

MoonLake Immunotherapeutics (NASDAQ: MLTX) uses at least 1 format(s):
MoonLake Immunotherapeutics (NASDAQ: MLTX) Email FormatsExamplePercentage
F.Last@moonlaketx.comJ.Doe@moonlaketx.com
49%
First.Last@moonlaketx.comJohn.Doe@moonlaketx.com
1%
F.Last@moonlaketx.comJ.Doe@moonlaketx.com
49%
First.Last@moonlaketx.comJohn.Doe@moonlaketx.com
1%

Frequently Asked Questions

Where is MoonLake Immunotherapeutics (NASDAQ: MLTX)'s headquarters located?

Minus sign iconPlus sign iconMoonLake Immunotherapeutics (NASDAQ: MLTX)'s main headquarters is located at Dorfstrasse 29 Zug, Zug 6300 CH. The company has employees across 3 continents, including EuropeNorth AmericaSouth America.

What is MoonLake Immunotherapeutics (NASDAQ: MLTX)'s official website and social media links?

Minus sign iconPlus sign iconMoonLake Immunotherapeutics (NASDAQ: MLTX)'s official website is moonlaketx.com and has social profiles on LinkedIn.

How much revenue does MoonLake Immunotherapeutics (NASDAQ: MLTX) generate?

Minus sign iconPlus sign icon As of November 2024, MoonLake Immunotherapeutics (NASDAQ: MLTX)'s annual revenue reached $3.8M.

What is MoonLake Immunotherapeutics (NASDAQ: MLTX)'s SIC code NAICS code?

Minus sign iconPlus sign iconMoonLake Immunotherapeutics (NASDAQ: MLTX)'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does MoonLake Immunotherapeutics (NASDAQ: MLTX) have currently?

Minus sign iconPlus sign iconAs of November 2024, MoonLake Immunotherapeutics (NASDAQ: MLTX) has approximately 94 employees across 3 continents, including EuropeNorth AmericaSouth America. Key team members include Chief Financial Officer: M. B.Chief Technical Officer: O. D.Chief Medical Officer: B. P.. Explore MoonLake Immunotherapeutics (NASDAQ: MLTX)'s employee directory with LeadIQ.

What industry does MoonLake Immunotherapeutics (NASDAQ: MLTX) belong to?

Minus sign iconPlus sign iconMoonLake Immunotherapeutics (NASDAQ: MLTX) operates in the Biotechnology Research industry.

What technology does MoonLake Immunotherapeutics (NASDAQ: MLTX) use?

Minus sign iconPlus sign iconMoonLake Immunotherapeutics (NASDAQ: MLTX)'s tech stack includes CookieYesFont AwesomePHPAkamai Web Application ProtectorMicrosoft TeamsGoogle Universal AnalyticsZoomTwenty Twenty.

What is MoonLake Immunotherapeutics (NASDAQ: MLTX)'s email format?

Minus sign iconPlus sign iconMoonLake Immunotherapeutics (NASDAQ: MLTX)'s email format typically follows the pattern of . Find more MoonLake Immunotherapeutics (NASDAQ: MLTX) email formats with LeadIQ.

How much funding has MoonLake Immunotherapeutics (NASDAQ: MLTX) raised to date?

Minus sign iconPlus sign icon As of November 2024, MoonLake Immunotherapeutics (NASDAQ: MLTX) has raised $400M in funding. The last funding round occurred on Jun 28, 2023 for $400M.

When was MoonLake Immunotherapeutics (NASDAQ: MLTX) founded?

Minus sign iconPlus sign iconMoonLake Immunotherapeutics (NASDAQ: MLTX) was founded in 2021.
MoonLake Immunotherapeutics (NASDAQ: MLTX)

MoonLake Immunotherapeutics (NASDAQ: MLTX)

Biotechnology ResearchZug, Switzerland51-200 Employees

MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases.

✕

Access Insights for MoonLake Immunotherapeutics (NASDAQ: MLTX) and Millions of Other Companies

Sign up for full access to MoonLake Immunotherapeutics (NASDAQ: MLTX) information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
Dorfstrasse 29 Zug, Zug 6300 CH
Website
moonlaketx.com
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2021
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $400M

    MoonLake Immunotherapeutics (NASDAQ: MLTX) has raised a total of $400M of funding over 3 rounds. Their latest funding round was raised on Jun 28, 2023 in the amount of $400M.

  • $10M

    MoonLake Immunotherapeutics (NASDAQ: MLTX)'s revenue is in the range of $10M

Section iconFunding & Financials

  • $400M

    MoonLake Immunotherapeutics (NASDAQ: MLTX) has raised a total of $400M of funding over 3 rounds. Their latest funding round was raised on Jun 28, 2023 in the amount of $400M.

  • $10M

    MoonLake Immunotherapeutics (NASDAQ: MLTX)'s revenue is in the range of $10M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for MoonLake Immunotherapeutics (NASDAQ: MLTX) and Millions of Other Companies

Sign up for full access to MoonLake Immunotherapeutics (NASDAQ: MLTX) information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.